Changes in gene expression of glucose transporters in lactating and nonlactating cows.
Glucose delivery and uptake by the mammary gland are a rate-limiting step in milk synthesis. It is thought that insulin-independent glucose uptake decreases in tissues, except for the mammary gland, and insulin resistance in the whole body increases following the onset of lactation. To study glucose metabolism in peak-, late-, and nonlactating cows, the expression of erythrocyte-type glucose transporter (GLUT1) and the insulin-responsive glucose transporter (GLUT4) in the mammary gland, adipose tissue, and muscle were assessed by Western blotting and real-time PCR. Our results demonstrated that the mammary gland of lactating cows expressed a large amount of GLUT1, whereas the mammary gland of nonlactating cows did not (P < 0.05). On the other hand, adipose tissue of late and nonlactating cows expressed a large amount of GLUT1, whereas the adipose tissue of peak-lactating cows did not (P < 0.05). There were no significant differences in the abundance of GLUT4 mRNA in adipose tissue and muscle, whereas GLUT4 mRNA was not detected in the mammary gland. The plasma insulin concentration was greater (P < 0.05) in nonlactating cows than in peak- and late-lactating cows. The results of the present study indicate that in lactation, GLUT1 expression in the mammary gland and adipose tissue is a major factor for insulin-independent glucose metabolism, and the expression of GLUT4 in muscle and adipose tissue is not an important factor in insulin resistance in lactation; however, the plasma insulin concentration may play a role in insulin-dependent glucose metabolism. Factors other than GLUT4 may be involved in insulin resistance.
Komatsu
T
T
Department of Animal Physiology and Nutrition, National Institute of Livestock and Grassland Science, Tsukuba, Ibaraki 305-0901, Japan. koma2@affrc.go.jp
Itoh
F
F
Kushibiki
S
S
Hodate
K
K
D000273:Adipose Tissue / Q000737:chemistry; D000818:Animals; D015153:Blotting, Western; D002417:Cattle / Q000145:classification / Q000235:genetics* / Q000378:metabolism; D017931:DNA Primers / Q000737:chemistry; D005260:Female; D015870:Gene Expression / Q000502:physiology*; D005947:Glucose / Q000378:metabolism; D051272:Glucose Transporter Type 1 / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology; D051275:Glucose Transporter Type 4 / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology; D024601:Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) / Q000032:analysis / Q000096:biosynthesis; D013006:Growth Hormone / Q000097:blood; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance / Q000235:genetics / Q000502:physiology; D007774:Lactation / Q000235:genetics / Q000502:physiology*; D008321:Mammary Glands, Animal / Q000378:metabolism*; D018482:Muscle, Skeletal / Q000737:chemistry; D016133:Polymerase Chain Reaction / Q000662:veterinary; D012333:RNA, Messenger / Q000032:analysis; D011986:Receptors, Somatotropin / Q000032:analysis / Q000096:biosynthesis; D013997:Time Factors
D017931:DNA Primers; D051272:Glucose Transporter Type 1; D051275:Glucose Transporter Type 4; D007328:Insulin; D012333:RNA, Messenger; D011986:Receptors, Somatotropin; D013006:Growth Hormone; D024601:Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+); D005947:Glucose